BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
192 hedge funds and large institutions have $3.12B invested in bluebird bio in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 59 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
67% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 63
Holders
192
Holding in Top 10
4
Calls
$59.5M
Puts
$64M
Top Buyers
| 1 | +$92.8M | |
| 2 | +$52.7M | |
| 3 | +$37.6M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$28.2M |
| 5 |
O
OrbiMed
New York
|
+$19.7M |
Top Sellers
| 1 | -$42.1M | |
| 2 | -$36.2M | |
| 3 | -$34.7M | |
| 4 |
Two Sigma Investments
New York
|
-$32.6M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$25M |